Polycystic ovary syndrome in women using valproate: A review

@article{Bilo2008PolycysticOS,
  title={Polycystic ovary syndrome in women using valproate: A review},
  author={Leonilda Bilo and Roberta Meo},
  journal={Gynecological Endocrinology},
  year={2008},
  volume={24},
  pages={562 - 570}
}
  • L. Bilo, R. Meo
  • Published 1 January 2008
  • Medicine
  • Gynecological Endocrinology
Valproate (VPA) is a highly effective drug successfully employed in several neuropsychiatric diseases. In the last 15 years, an increased prevalence of polycystic ovary syndrome (PCOS) associated with VPA use has been reported in both women with epilepsy and women with bipolar disorders. However, data on this subject are contrasting and it is possible that different factors might play a role in the development of PCOS in these patients. The risk of developing PCOS during VPA treatment seems to… 
View on Taylor & Francis
ncbi.nlm.nih.gov
57 Citations
Highly Influential Citations
1
Background Citations
19

57 Citations

Citation Type

Citation Type

Valproate-Induced Polycystic Ovary Syndrome in a Girl with Epilepsy: A Case Study.
TLDR
The risk of PCOS developing in patients with epilepsy is known to be high, and the association of VPA with PCOS is well established, so physicians should carefully monitor the patients' weight and menstruation, and immediately perform ovarian imaging and hormonal examinations if any abnormalities are observed.
Secondary polycystic ovary syndrome: theoretical and practical aspects
TLDR
If accepted, these concepts could help clinicians to perform in-depth investigations of the potential factors or disorders responsible for the development of these specific forms of secondary PCOS and contribute to develop further research on factors and mechanisms involved in theDevelopment of the classic and the nonclassic PCOS phenotypes.
Psychiatric disorders in women with polycystic ovary syndrome.
TLDR
The higher prevalence of psychiatric disorders in patients with PCOS, especially depression and anxiety disorders, may be due to both hyperandrogenism and the resulting somatic symptoms.
MANAGEMENT OF ENDOCRINE DISEASE: Secondary polycystic ovary syndrome: theoretical and practical aspects.
TLDR
If accepted, these concepts could help clinicians to perform in-depth investigations of the potential factors or disorders responsible for the development of these specific forms of secondary PCOS and contribute to develop further research on factors and mechanisms involved in theDevelopment of the classic and the nonclassic PCOS phenotypes.
Neuroendocrine Impairments of Polycystic Ovary Syndrome
TLDR
An overview of what is known about alterations in the steroid hormone-sensitive GnRH neuronal network that may underlie the neuroendocrine defects in clinical PCOS is provided, with a particular focus on those that may contribute to impaired progesterone negative feedback, and the likely role of androgens in driving this impairment.
Polycystic Ovary Syndrome (PCOS) and Sexual Dysfunctions
TLDR
Focus on sexual dysfunctions in PCOS has been emphasized only recently after high rates of its prevalence have been found and proper assessment and management of sexual Dysfunctions should be given its due importance.
Endocrine effects of valproic acid therapy in girls with epilepsy: a prospective study.
Risk of Psychiatric Disorders following Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study
TLDR
PCOS might increase the risk of subsequent newly diagnosed depressive disorder, anxiety disorder, and sleep disorder, which has often been reported in the literature to be comorbid with PCOS.
Pathological pulses in PCOS
TLDR
This mini-review will briefly describe the pathology of PCOS associated with high frequency GnRH/LH pulses and then highlight what is currently known, and yet to be discovered, about the central mechanisms involved.
Reproductive health in patients with epilepsy
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 95 REFERENCES
Polycystic ovary syndrome and epilepsy: a review of the evidence.
TLDR
On the whole these studies suggest that women with epilepsy are at risk for developing reproductive endocrine disorders, even if there is not yet definite evidence that PCOS may be over-represented in these patients nor that VPA may be the cause of endocrine problems.
A Putative Relationship between Valproic Acid and Polycystic Ovarian Syndrome: Implications for Treatment of Women with Seizure and Bipolar Disorders
TLDR
Evidence bearing on a putative relationship between VPA and bipolar disorder in women with epilepsy and polycystic ovarian syndrome is reviewed.
Polycystic ovary syndrome in patients with focal epilepsy: a study in 93 women
Epilepsy and polycystic ovary syndrome: where is the link?
TLDR
A pathogenic theory in which both epilepsy and valproate play different and significant roles in inducing reproductive endocrine disturbances in women with seizures is proposed.
Polycystic ovaries, obesity and insulin resistance in women with epilepsy
TLDR
The frequency of PCOs in 27 % of epileptic women seems to be similar to that in the general population with a frequency of 20–30 %, which indicates that VPA increases glucose stimulated pancreatic insulin secretion, which might be followed by an increase in body weight.
Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.
TLDR
Menstrual disturbances, polycystic ovaries, and hyperandrogenism are often encountered in women taking valproate for epilepsy.
Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder.
TLDR
These results suggest high rates of menstrual disturbances and polycystic ovary syndrome in women with bipolar disorder currently receiving valproate.
Altered ovarian function and cardiovascular risk factors in valproate-treated women.
Association of Polycystic Ovaries with the Use of Valproic Acid in Jordanian Epileptic Patients
TLDR
An association between the use of VPA and PCO, hyperandrogenism, obesity and menstrual abnormalities is suggested, and clinicians should consider performing an assessment of ovarian structure and function, especially if women receiving VPA therapy develop menstrual cycle disturbances during treatment.
Valproate Is Associated with New-Onset Oligoamenorrhea with Hyperandrogenism in Women with Bipolar Disorder
...
1
2
3
4
5
...